MPEP (drug)

MPEP, also known as 1-(α-methylphenethyl)pyrrolidine, is a stimulant drug of the phenethylamine, amphetamine, and phenylethylpyrrolidine families.^[1][2] It is the α-methyl derivative of phenylethylpyrrolidine (PEP).^[1][2] Notable derivatives of MPEP include prolintane (the α-propyl homologue), α-PPP (the β-keto or cathinone derivative), α-PVP (the β-keto and α-propyl homologue), pyrovalerone (4-methyl-α-PVP), and MDPV (3,4-methylenedioxy-α-PVP), among others.^[1][3] These compounds are known to act as norepinephrine–dopamine reuptake inhibitors (NDRIs) to produce their stimulant effects.^[1][3] MPEP was first described in the scientific literature by R. V. Heinzelman and B. D. Aspergren by 1953.^[1][2]

Other names1-(α-Methylphenethyl)pyrrolidine; α-Methylphenethylpyrrolidine; α-Methyl-PEP; 1-(1-Methyl-2-phenylethyl)pyrrolidine

Drug classStimulant

ATC code

• None

PubChem CID

• 53665923

Quick facts Clinical data, Other names ...

MPEP

Clinical data
Other names	1-(α-Methylphenethyl)pyrrolidine; α-Methylphenethylpyrrolidine; α-Methyl-PEP; 1-(1-Methyl-2-phenylethyl)pyrrolidine
Drug class	Stimulant
ATC code	None
Identifiers
IUPAC name 1-(1-phenylpropan-2-yl)pyrrolidine
PubChem CID	53665923
ChemSpider	57577614
Chemical and physical data
Formula	C13H19N
Molar mass	189.302 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC(CC1=CC=CC=C1)N2CCCC2
InChI InChI=1S/C13H19N/c1-12(14-9-5-6-10-14)11-13-7-3-2-4-8-13/h2-4,7-8,12H,5-6,9-11H2,1H3 Key:AWNZMWZMSDWFCV-UHFFFAOYSA-N

Close